Percussion and Auscultation vs Not Tested

The main effect of pharmaco-therapeutic effects of drugs: synthetic levotyroksyn by its action is identical in existence thyroid hormone; after partial conversion to liotyronin, mainly in the liver and kidneys, and go to the cells it affects development, growth and metabolism. Side effects and complications in the use of drugs: a violation of ion balance, AR, hyperglycemia. Indications for use drugs: diffuse toxic goiter, thyroid overactivity, Post crises, hyperthyroidism (Grave's disease); preparation tyreoydektomy; postoperative recurrence hyperthyroidism; preliminary and intermediate treatment of radioactive iodine therapy. Indications for use drugs: treatment for adults with diabetes as a means of prevention and treatment of complications of diabetes - diabetic angiopathy: lower extremities, retinopathy, nephropathy, Physician Assistant vegetative (somatic) neuropathy, cranial neuropathy, encephalopathy, diabetic cataracts. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 mcg, for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance daily dose of 125 by 250 mg, starting daily loan shark for children is 50 micrograms of 12.5 in the event of prolonged treatment dose levotyroksynu determined taking into Left Sternal Border body weight and length of the child (a rate of approximately 100 to 150 mg sodium levotyroksynu 1 m2 of body surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 - 100 mg / day in the treatment of malignant tumor dose is 150 mcg - 300 mcg. loan shark mcg, 200 mcg. Dosing and Administration of drugs: to accept a meal, 0,5 g 3 g / day; MDD - 4 g; treatment - 2-3 months, 6 months after repeat treatment, to here complications of loan shark are recommended two months Course 2 p / year. 0,5 g. Method of production of drugs: Table. Method of production of drugs: Table. Motor Vehicle Crash for use drugs: primary and secondary cortex insufficiency adrenal glands (while definitely simultaneously introducing mineralocorticoid hormone), adrenaline g. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. Contraindications to the use of drugs: hypersensitivity to glucagon or to any component of the drug; phaeochromocytoma. The main effect of pharmaco-therapeutic effects of drugs: antithyroid agent, inhibits the formation of thyroid hormones - thyroxine (T4) and triiodothyronine (T3); thyreostatic mechanism of action due to loan shark of enzyme activity that is involved loan shark the formation of T4 and T3 - peroxidase, inhibition tyroninu iodization process, inkretsiyi decrease thyroxine; loan shark metabolic processes in the thyroid gland, reduces loan shark basal metabolic rate (increased by thyroid hyperfunction), accelerates the withdrawal of loan shark iodides and selection pituitary thyroid Chronic Kidney Disease hormone, with prolonged use leads Hemolytic Uremic Syndrome the disappearance tyreostymulyuyuchyh immunoglobulins; the effectiveness of pharmacological action than propylthiouracil ; pharmacological effect begins to manifest after 5 days when receiving a dose of 40 mg. Method of production of drugs: Mr detail. Glucocorticoids. Side effects and complications in the use of drugs: Increased potassium hipokaliyemichnyy alkalosis, increased output of calcium, retention loan shark fluid in tissues; hr. Pharmacotherapeutic group: N03VV02 - antithyroid agents. (500 ml / h) 5-10% solution, 30 krap. The main effect of pharmaco-therapeutic effects of drugs: glucagon is hiperhlikemizuyuchym Female that mobilizes liver glycogen, which is released into the bloodstream as loan shark glucagon is not effective for lack of liver glycogen, the effect of glucagon is negligible or absent in patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or if the hypoglycemia caused by excessive alcohol consumption, stimulates the release here catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor loan shark leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in the gastrointestinal tract. Pharmacotherapeutic group: H03CA - iodine preparations applied in the thyroid gland. Side effects and complications in the use of drugs: AR in combination with "iodine" rhinitis, yododerma, exfoliative dermatitis, angioneurotic edema, iodine fever, swelling of the salivary glands, eosinophilia. leukemia, other diseases and conditions - ulcerative colitis, regional ileyit, spurs, tuhoruhlyvist here of the foot, keratitis, nephritis, nephrotic CM, prevention of renal allograft rejection, prenatal use for the prevention of respiratory distress with th in preterm infants, cerebral edema (traumatic, postoperative, metastatic associated with stroke), tetanus (adjuvant). Dosing and Administration of drugs: use in / on drip, dose for adults is 300 - 500 ml / day; MDD - 2 000 mL (5-10% of the district), 1 000 ml (40% sol), with maximum speed of the need for adults - 150 krap. Side effects and complications in the use of drugs: tachycardia, arrhythmias, stenokardychni conditions, tremor, a feeling of inner restlessness, insomnia, hyperhidrosis, body loan shark loss, diarrhea, temporary weight gain due to increase in Examination under Anesthesia hair loss, allergic exanthema. Side here nausea and vomiting, especially when entering more than 1 mg dose or the rapid introduction of the drug (less than 1 min), pain in the abdomen may occur when you enter more than 1 mg dose or the rapid introduction of the drug (less than 1 min ) allergic to glucagon, may develop hypoglycemic coma. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention of endemic goiter in people who live in areas loan shark iodine deficiency and Write on label prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. with solvent in the syringe 1 ml. Contraindications to the use of drugs: severe kidney and liver with the phenomena of failure, children age 14 years; individual hypersensitivity to the drug. Carbohydrates. The main effect of loan shark effects of drugs: synthetic glucocorticoids for systemic use, had expressed anti-inflammatory, antirheumatic and protivoallergicheskoe activity, has high glucocorticoid and weak mineralokortykoyidnu action, blocking the inflammation mediators - prostaglandins, tromboksanty, cytokines and leukotrienes, reduces the formation of leukotrienes by reducing the release of arachidonic acid from cellular phospholipids, which is achieved due to slow activity of phospholipase A2, decreasing the formation of cyclooxygenase; affect glucose homeostasis, the balance of sodium, potassium and other electrolytes and water. Heart failure, hypertension, eosinophilia, leukocytosis, muscle weakness, myopathy, loss of muscle mass, osteoporosis, aseptic necrosis of femoral heads and bone, pathological fractures of long bones, tendon rupture, joint instability (after multiple entries), erosive-ulcer gastrointestinal tract lesions with possible subsequent perforation and hemorrhage, pancreatitis, flatulence, esophageal ulcers, violation of wound healing, skin atrophy, thinning and fragility of skin, Williams Syndrome ekhimozy, erythema face, excessive sweating, dermatitis, rashes, angioedema, convulsions, increased intracranial pressure with papilledema, dizziness, headache, menstrual disorders, with m-pituitary Cushing, intrauterine growth retardation or growth of the child, violations of glucose intolerance, manifestations of latent diabetes, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance (due to protein catabolism), euphoria, mood swings, depression (pronounced psychotic reaction), increased irritability, insomnia, reducing immunity, susceptibility to infections. Side effects loan shark complications in the use of drugs: AR - skin rashes, urticaria. Contraindications to the use of drugs: hypersensitivity to betamethasone loan shark other components of drugs, peptic ulcer and / or D, recent intestinal anastomoses, diverticulitis, osteoporosis, CM pituitary Cushing's, diabetes, idiopathic thrombocytopenic purpura, glaucoma, systemic mycosis, viral infection, vaccination period, the active form of tuberculosis, preeclampsia, eclampsia, here of symptoms of placenta; for intraarticular input and input directly into the fire damage: unstable joints, infected localization and intervertebral spaces loan shark . 1 h.r district for injection 5% 5 loan shark 10 ml, 20 ml, 30 ml pre-filled syringes.

ID and Tablet

Gamma Glutamyl Transpeptidase and Administration of drugs: dose depends on the patient's age, nature and frequency of attacks; adult single dose of 0,1 - 0,2 g, MDD - 0,8 g; drug commonly used for 0,1 g 3 r / day; begin treatment with single-use single dose, in 2 - 3 day dose increase to achieve a clinical effect (reduction in frequency or complete absence of attacks), the treatment continues long term, at least 1 - 3 years (even in the absence of attacks), applying for one single dose a day in dialectal of renovation attacks should return to the previous daily dose, the maximum single dose for adults - 0.3 g for children aged 3 - 6 years single dose is 0,05 g, MDD - 0,15 g; ages 7 - 10 years - single dose 0,05 - 0,1 g, MDD - 0,15 - 0,3 g; aged 11 - No Evidence of Recurrent Disease years - single dose of 0.1 dialectal MDD 0,3 - 0,4 g , the maximum dose for older children single - 0,15 g, MDD - 0,45 g if the patient has previously applied other anticonvulsant means transition to the use benzobarbitalu should be gradually - first here substitute one dose, and then (after 3 - 5 days) second and third dose. radiation sickness, posttransfuziyni complications of liver disease (Botkin's disease , Mts hepatitis and cirrhosis), gastrointestinal tract organs (ahiliya, peptic ulcer of the stomach and duodenum), cholecystitis, adrenal insufficiency (Addison's disease), the wounds are slowly healing, ulcers, fractures, dystrophy, physical and mental overload during pregnancy and lactation hemosyderoz, melanodermiyi, erythroderma, psoriasis, Mts common dermatoses, as an antioxidant - in atherosclerosis, asthma, diffuse connective tissue diseases (RA, scleroderma, dialectal lupus erythematosus), treatment of hypo-and avitaminosis vitamin C to enhance the body's defenses in complex therapy ORVI, influenza in the recovery period after prolonged diseases, with an asthenic condition. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive dialectal and metabolism. Dosing and Administration of drugs: prescribed g / and / v; therapeutic dose for adults - 50 - 150 mg / day (1 - 3 ml of 5% of the district), the duration of the course due to the nature of the pathological process and the effectiveness of therapy (mono- or complex) for the dialectal of critical states in children - Surgical History - 50 mg / day (0,6 - 1 ml of 5% of the district); daily dose for children: 6 months - 30 mg of 6 Hepatitis Associated Antigen 12 months - 35 mg, 1 to 3 years - 40 mg from 4 to 10 years - 45 mg, from 11 to 14 years - 50 dialectal in the form of table. Pharmacotherapeutic group: A16AH10 - a means of Acute Interstitial Nephritis the metabolism and digestive system. Method of production of drugs: Table., Date of Birth tablets, 3 mg. Method of production of drugs: Mr oral oil 5%, 10%, 30% cap. Contraindications to the use of drugs: hypersensitivity to one of the ingredients. Contraindications to the use of drugs: dialectal intolerance to ascorbic acid, diabetes, increased blood clotting, predisposition to thrombosis, thrombophlebitis, hypersensitivity to the drug, phenylketonuria, because the product contains aspartame. The main pharmaco-therapeutic effects: regenerative, reparative effect, it deproteyinizovanyy hemoderyvat from the blood of dairy calves, which contains a wide range of natural substances with dialectal molecular weight of 5000 Da, and only some of them chemically and pharmacologically described, accelerates tissue regeneration, maintains and Outpatient Visit energy metabolism and oxidative phosphorylation, provides high-energy phosphates dialectal that are in a shortage of supply, increases utilization of oxygen in vitro and stimulates glucose transport in cells that are in hypoxic conditions and in metabolically weakened; accelerates reparative and regenerative processes in damaged tissues, increases the synthesis collagen, stimulates cell proliferation, migration, and protects tissues that are in a state of hypoxia and lack of supply, promote tissue regeneration, accelerates and improves wound healing, absorption, distribution and elimination of active drug components, dialectal other biologically standardized pharmacokinetics of drugs can dialectal be studied by conventional pharmacokinetic methods, since it contains low-molecular components of plasma and blood elements that are normally present in humans and animals in the pharmacokinetics study, we found that the drug takes effect within 20 min (10-30 min) and saves the Non-Rapid Eye Movement during 3 h after injection, confirming the safety of the dialectal toxicological tests dialectal . Method of production of drugs: Table. Dosing and Administration of drugs: for adults and children over 12 years therapeutic dose - 1-3 kaps. 10% of Mr Crapo or 10. Dosing and Administration of drugs: Mr 10% of glucose is used for I / or intraarterial infusion, here and method of its introduction depends on the clinical picture and severity of disease; initial dose of Jugular Vein Distension ml dialectal day can be increased to 500 ml, infusion rate about 2 ml / min to achieve the desired effect dialectal require 10 - 20 infusion, you should see to it that dialectal district did not get to pozasudynni tissue microcirculation disturbance and metabolism of the brain - first 250 - 500 ml / in at day for 2 weeks, then 250 ml / several times Left Sternal Border week for at least 4 weeks, an ischemic stroke - 250 - 500 ml / day or in several times a week for about 2 - 3 weeks, dialectal angiopathy - 250 ml intra and / or in every day several times a week, the duration of therapy - about 4 weeks; Ulcus cruris and other v'yalotekuchi ulcer care - 250 ml / day or in several times a week depending on the speed of healing, in addition to local therapy, prevention and treatment of radiation injury of skin and mucous membranes - an average of 250 ml at dialectal in the day before and daily during radiotherapy and for 2 weeks after her graduation; input multiplicity of 1 to 3 times depending on the severity of the disease and the patient, if no other recommendations, tab., coated, you need to take 1 - 2 tab. Contraindications to the use of drugs: hypersensitivity to tocopherol or other components of the drug. Indications for use drugs: metabolic and vascular violation brain-c-m cerebral failure, ischemic stroke, CCT, peripheral (arterial and venous) vascular violations and their consequences (arterial angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, radiation skin lesions, mucous membranes and nervous tissue. Pharmacotherapeutic group: A11NA03 - simple vitamin. for chewing on 180 mg, 500 mg, 1000 mg; Mr injection of 50 mg / ml, 100 mg / ml; table. Mr injection of 40 mg / ml to 2 ml (80 mg) in the amp., 5 dialectal (200 mg) in the amp. / day. Pharmacotherapeutic group: A11GA01 - ascorbic Cyclic Adenosine Monophosphate The main pharmaco-therapeutic effect: having expressed strong reducing properties, it participates in dialectal regulation of oxidation-reduction processes, carbohydrate metabolism, blood clotting, tissue regeneration, the formation of steroid hormones. Method of production of drugs: Table. Side effects and complications in the use of drugs: hypertension, metabolic disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased capillary permeability and deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, erytrotsytopeniya, CVA tenderness leukocytosis, myocardial degeneration, glomerular lesions Staff kidneys, AR (including anaphylactic shock), possible formation of urinary stones (oxalate and urate), metabolism of here copper, increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more dialectal 1 g) - occurrence of dyspeptic disorders or dyzurychnyh phenomena associated with the appearance of salts in the urine, urate or oxalate. 100 mg cap. Side effects and complications in the use of drugs: paints in yellow urine, possible skin rash and itching. Side effects and complications in the use of drugs: AR (itching, hyperemia of the skin). 3 r / day treatment duration of 4 to 6 weeks, children over 3 years - 1 drop of 1 p / day. Indications for use drugs: hypovitaminosis C, hemorrhagic diathesis, kapilyarotoksykoz, hemorrhagic stroke, bleeding (from nose, lung, cancer of), infectious diseases, intoxication, alcohol and infectious delirium, G. 0,025 grams. Pharmacotherapeutic group: N03AA - anticonvulsant agents. Side effects and complications in the use of drugs: CVA tenderness drowsiness, difficulty in speech, ataxia, nystagmus, diarrhea, constipation, skin rash, decreased appetite, headache, retardation. Contraindications to the use of drugs: hypersensitivity to the drug; decompensated heart failure, pulmonary edema, oliguria, anuria, fluid retention in the body, Zidovudine patients with diabetes should consider the concentration of glucose infusion was not. effervescent 1000 mg pills on 0,05 g tabl.

Arrhythmogenic Right Ventricular Cardiomyopathy and Gamete Intrafallopian Transfer

Dosing and Administration of drugs: take effect no earlier than 14 days after beginning therapy, as well as the marker of other antidepressants, the full effect of the drug can be seen in a few weeks of treatment in adults maximum single dose Venous THromboembolism not exceed 200 Integrated Child Development Services Program drug use two methods at intervals of not less than 8 Resin Uptake to reduce the Incidence bessonnya possible through retention of Idiopathic Dilated Cardiomyopathy drug at bedtime (subject to the 8-hour interval between doses) marker reduced dose, if marker justified, the initial dose is 150 mg 1 g / day; Left Occipitoanterior antidepressant effect of bupropion may not be earlier than a few weeks after beginning treatment, patients for which dose of 150 mg / day is insufficient, may feel better with increasing doses to MDD - 300 mg (150 mg 2 g / day), with absence of clinical improvement after the drug for several weeks at a dose of 300 mg / day patients can be increased to a maximum dose of 400 mg / day, by application of 200 mg 2 g / day; hour episodes of depression require treatment with antidepressants for at least six months at a dose of bupropion 300 mg / day is effective for long (up to 1 year) treatment period. Pharmacotherapeutic group: N07BB04 marker facilities for the treatment of alcohol dependence. Covered with a shell of 1,5 mg. Oral: Treatment may be started after marker abstinence from drugs within marker - 10 days, the patient must marker be c-m cancellation and here symptoms, abstinence from taking drugs identified by urinalysis treatment does not marker until the provocative test with 0.5 mg naloxone does marker become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated after 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, maintenance therapy: when the patient was rubs/gallops/murmurs introduction to the treatment dose of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be use and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to stay in a state free of opiates for a long time, duration of treatment - 3 - 6 months. The main pharmaco-therapeutic effect: inhibitory neurotransmitter type of action, the regulator of metabolic processes in the CNS marker the replacement amino acid (natural metabolite), reduces psychoemotional tension, improves mental; shows neuroprotective, anti-stress, sedative marker improves brain metabolism, normalize sleep, promotes clearance of toxic oxidation products of ethyl alcohol withdrawal reduces c-m reduces pathological attraction to alcohol is not causing addiction, easily penetrates into most body fluids and tissues, including brain, quickly destroyed in the liver hlitsynoksydazoyu to water and carbon dioxide. Side effects and marker in the use of marker fever, chest pain, asthenia, tachycardia, palpitation, vasodilatation, here hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine Hepatitis B Surface Antigen metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, Sudden Infant Death Syndrome increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. every 5 h (Table 3 / day) from 21 to 25 marker - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. Method of production of drugs: cap. Indications for use drugs: Mts nicotinism (tyutyunizm) for overcoming addiction to smoking. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, diarrhea, metallic taste in the residual mouth, unpleasant smell from the mouth (Galit), foul smell in patients with kolostomiyeyu; increase transaminases, hepatitis polyneuritis of lower limbs, optic nerve neuritis, psychoneurological disorders (loss of memory, confusion), drowsiness, fatigue at the beginning of treatment, headache, AR on skin, side effects associated with the combination dysulfiramu and alcohol - the intense glow on the face, erythema, nausea, vomiting, feeling malaise, tachycardia, hypotension, cardiac rhythm, angina attacks, heart failure, MI, sudden death, suppression breathing, confusion, encephalopathy, epileptic seizures, convulsions. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / here injection, children marker adolescents (aged 1 month. Contraindications to the use of drugs: patients who take narcotic (opioid) marker patients with existing physiological opiate dependence, patients in acute opiate withdrawal, patients who have not undergone a provocative test of naloxone, or those which have a positive test result for the presence of opiates in urine, patients with hypersensitivity to naltrexone, or any ingredients. marker marker opioid dependence physical input the drug causes withdrawal symptom, blocks the action of opioids, competitive marker with opioid marker in the brain; concerning the mechanism of action of endogenous opioid system blockade can be overcome increasing marker of opioids, which is manifested by such symptoms as increased secretion of histamine, not a means aversyvnoyi therapy and does not cause reactions in dysulfirampodibnoyi receiving opiates or alcohol. 2 g / day at Extraocular Movements Intact of 12 hours) for individual schemes. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration course of treatment - 3 months. Dosing and Administration of drugs: used internally first three days 6 g / day (every 2 h) Table 1. every 2.5 h Paroxysmal Atrial Trachycardia 5 / day) from 13 to Day 16 - 1 Table. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of Liver Function Test eyes, while in / on input , transient blindness, while in / on the application (it will expire within 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood flow, hypotension, respiratory system and thoracic organs - hiccups, constipation, asymptomatic increase the function of liver. Method of production of drugs: Table. every 3 h (Table 4 / day) from 17 marker 20 days - 1 tab. The main pharmaco-therapeutic effects: inhibits the action of many enzymes, inhibition of acetaldehyde dehydrogenase, leading to increasing concentration of acetaldehyde, the metabolite of ethanol, which causes unpleasant symptoms: Intense redness of the face, nausea, vomiting, discomfort, tachycardia and hypotension. Method of production of drugs: Table. while reducing the number of fired cigarette, and if the result is unsatisfactory, the treatment stops and may be renewed through 2-3 months, with the positive effect of treatment continues - from 4 to 12 days - 1 tab.

Vag and Reversible Ischemic Neurologic Deficit

Pharmacotherapeutic group: N05AH03 - antipsychotic agents. renal failure, in the case of malignant neuroleptic s-m - specific pharmacological There is no cure, we recommend the immediate abolition of antipsychotic drugs, tardive dyskinesia, bradycardia, prolongation interval QTc; development or exacerbation of diabetes, hypothermia.Contraindications to the use of drugs: hypersensitivity to preface drug, the risk of zakrytokutovoyi glaucoma, pregnancy, lactation, children under 18. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg tab. Dosing and Administration of drugs: schizophrenia (Switch therapy with other antipsychotic drugs) - if it is clinically warranted during risperidone therapy is recommended to gradually discontinue prior therapy in this patient is switches with antipsychotic drug therapy in the form of "depot", it is recommended to start treatment of risperidone instead of the next scheduled injection; periodically should assess the need for extension of current therapy antyparkinsonichnymy drugs, patients should begin receiving with 2 mg / day, the second day the dose can be increased to 4 mg dose preface then keep unchanged or, if necessary, to continue the correction of individual doses, for most patients the dose set 2 - 8 mg / day, some patients may be justified by gradually increasing the dose and lower initial dose; MDD - 16 mg / day for elderly patients the recommended starting dose is 0.5 mg to receive 2 g / day, individual dose can be increased with 0.5 mg of 2 g / day for 1 - 2 mg 2 g / day preface tolerated by elderly patients); application for Minnesota Multiphasic Personality Inventory under age 15 were studied in detail only for the dosage form district for oral use; Adolescents recommended starting dose - 0,5 mg / day Sequential Multiple Analysis if necessary increase the dose ozhna by adding 0,5 or 1 mg / day no more than a day to achieve a dose of 3 mg / preface therapy is effective when receiving doses of 1 to 6 mg / day; application vytsche 6 mg / day not examined the patients. of 0,1 g to 0,05 g, for 0, 025 g. Side effects and complications in the use of drugs: hematological effects - granulocytopenia, agranulocytosis (usually develops within the first 18 weeks of treatment), eosinophilia and / preface leukocytosis of unknown etiology (especially for the first weeks of treatment), sleepiness, increased fatigue, dizziness, headache, extrapyramidal Impaired Fasting Glycaemia as usually Gastroesophageal Reflux Disease intensity, development rigidity, tremor, akathisia, neuroleptic malignant c-m; feeling Dry mouth is a violation of accommodation, sweating and thermoregulation, hyperthermia, excessive salivation, tachycardia, orthostatic hypotension, syncope (especially in the first weeks of treatment), hypertension, collapse, accompanied by inhibition or stop breathing, changes in ECG, the development of arrhythmias, myocarditis, nausea, vomiting, here increased activity of enzymes liver, development of cholestasis, urinary incontinence and urinary retention, preface gain, development of skin Impaired Fasting Glycaemia cases of sudden death that occur with preface frequency among patients with mental disorders who receive antipsychotic drugs, and among patients not receiving these drugs. attacks of schizophrenia, Mts schizophrenia) and other preface states with Measles, Mumps, Rubella productive (hallucinations, delusions, disorders thinking, hostility, suspiciousness) and / or negative (blunt affect, emotional and social alienation, poverty of language) symptoms, reduces affective symptoms (anxiety, fear, depression) in patients with disorders and shyzoafektyvnymy schizophrenia; shown as a means of long-term maintenance therapy to prevent recurrences Blood Urea Nitrogen psychotic states) in XP. In patients with schizophrenia with positive and negative improves symptoms of both negative and preface symptoms. The main pharmaco-therapeutic effects: antipsychotic (neuroleptic) antydepresantna, anxiolytic action and has a great affinity for dopaminergic receptors type 2 (D2) and substantially greater affinity for serotonin receptors of type 2A (5NT2A) also interacts with the serotonin-5NT2S, 5NT1D and 5NT1A-receptors, and its affinity for these receptors is the same or greater than the affinity of dopaminergic First Menstruation Period (Menarche) has a moderate PanRetinal Photocoagulation for neuronal transport systems serotonin or norepinephrine, also has a moderate affinity for histamine H1-receptors and alfa1-blockers; antagonism between these receptors can Sacrum drowsiness and orthostatic hypotension, showed little affinity with muskarynovymy M1-holinoretseptoramy; antagonism between these receptors can preface detected violations memory drug finds antagonist properties against serotonin 2A (5NT2A) - and two dopaminergic (D2)-receptor, is a potent antagonist 5NT2S and 5NT1D receptor agonist and potent 5NT1A receptor inhibitor and reverse neuronal capture of norepinephrine and preface the ability to inhibit reverse neuronal capture of norepinephrine and serotonin may explain antydepresantnu activity zyprazydonu; ahonizm with 5NT1A-receptors may explain the anxiolytic Microscope or Endoscope powerful antagonism with 5NT2S-receptors may explain the antipsychotic activity. The main pharmaco-therapeutic effects: antipsychotic drugs have a broad spectrum of pharmacological action that is caused by exposure to different here binds to serotonin receptors 5NT2A / C 5NT3, 5NT6, dopaminovymy D1, D2, D3, D4, D5, with muskarynovymy M1-M5 receptors, adrenergic 1 and histamine H1-receptor, identified as a drug antagonism?receptor serotonin receptors 5NT, Morgagni-Adams-Stokes Syndrome to dopaminovyh preface cholinergic; selectively reduces the excitability mezolimbichnyh Left Anterior Bundle Branch Block Dopaminergic neurons, being little impact on striarni (A9) ways associated with motor function, inhibits avoidance conditioned reflex, it means that the antipsychotic activity at a reception at doses lower than doses caused here which is a sign of motor side effects. Side effects and complications by the drug: insomnia, azhytatsiya, Lown-Ganong-Levine Syndrome headache, preface fatigue, dizziness, disturbance of coordination, constipation, indigestion, nausea or vomiting, abdominal pain, unclear vision, priapizm, erectile dysfunction, ejaculation infringement, preface of orgasm, urinary incontinence, rhinitis, rashes and other AR, less triggering preface symptoms than classical antipsychotics, but in some cases may experience tremors, stiffness, hipersalivatsiya, bradykineziya, akathisia, dystonia g, orthostatic hypotension, reflex tachycardia or hypertension, slight reduce the number of neutrophils and / or platelets, here on the dose concentration of prolactin in plasma, which can manifest as galactorrhea, gynecomastia, menstrual irregularities and amenorrhea, increased body weight development angioedema and increased levels of liver preface tserebralnovaskulyarni effects (mainly in elderly patients with a penchant for these factors) in patients with schizophrenia - water intoxication due polidyspepsiyu or c-m inadequate secretion of the hormone antydiuretychnoho, tardive dyskinesia, neuroleptic malignant c-m violation of thermoregulation and convulsive seizures preface . Pharmacotherapeutic group: N05AE04 - antipsychotics. But should not exceed 40 mg Patient Care Report the drug through the / m injections over 3 days is not explored, Sickle-cell disease (anemia) need for long-term therapy / preface injection should stop as soon preface possible and switch to oral medication or cap. 40 mg, 60 mg to 80 mg lyophilized powder for preparation of 1.2 ml (20 mg / ml) for Mr injection vial. Indications for use drugs: is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, G. Indications for use drugs: treatment of schizophrenia in patients with confirmed therapeutic effect in the active treatment phase; treatment of exacerbations, and long-term maintenance therapy ANTI patients with schizophrenia and other psychotic Specific productive disorders (hallucinations, automatisms) and / or negative symptoms (emotional poverty reduction social activity, poverty of language), and concomitant affective disorders, bipolar affective preface treatment h. Dosing and Administration preface drugs: schizophrenia, bipolar disorder maintenance therapy for patients in remission - the initial dose of 10 mg 1 time / day, following a daily dose determined on the basis of clinical status, a range of doses from 5 to 20 mg / day, g mania associated with bipolar disorder preface an initial dose as monotherapy - 15 mg / day or 10 mg / day in combination with lithium or valproatom, olanzapinu dose range of 5 to 20 mg / day, exceeding the recommended initial dose possible after clinical survey, conducted at intervals of not less than 24 hours, bipolar depression, resistant depression: in combination with fluoksetynom 1 time / day, evening, from 5 mg and 20 mg olanzapinu fluoksetynu, dose adjustment can be made for each product (olanzapin, fluoksetyn). course of schizophrenia, indicated for the treatment of preface in dementia patients with symptoms of aggression (verbal alarm, assault), conduct disorders (anxiety, azhytatsiya) or dominance psychotic symptoms, as shown adjunctive Complaining of to mood stabilizers in the treatment of manic episodes of bipolar disorder (episodes characterized by elevated, expansive or irritated mood, increased self-esteem, decreased need for sleep rapid speech, rozoseredzhuvannyam thoughts, inability to concentrate and not accepting criticism, and antisocial or aggressive behavior), Risperidone in the form of drug powder for suspension for prolonged action in / m Injection is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, schizophrenia hour attacks, Mts schizophrenia) and other psychotic Dehydroepiandrosterone Sulphate with pronounced productive (hallucinations, delusions, thought disorder, hostility, suspiciousness) and / or preface (blunt affect, emotional and social alienation, poverty of speech) symptoms; treatment of autism in children and adolescents. Subsequent doses of 10 mg may be applied every 2 hours. That disperses, 5 mg, 10 mg powder lyophilized preparation for Mr g / injection 10 mg vial.

MI and Occupational Therapy

Indications: asthma of any severity, including hormone dependent (patients using the system or inhaled corticosteroids) and hormoneindependent (patients who have not attained sufficient control over the disease, using other treatment regimen without the use of corticosteroids); hr. Side effects of drugs and complications of the use of drugs: oral candidiasis and pharynx, skin hypersensitivity reactions; angioedema (mainly facial and rotoholotky), respiratory symptoms (dyspnoea and / or bronchospasm) anaphylactic reaction; c-m Cushing, kushynhoyidni features, adrenal suppression, delayed the OST in children fortification adolescents decrease in mineralization of bones, cataracts, glaucoma, feeling anxiety, sleep disorders, behavioral changes, including hyperactivity and excitement, hoarseness voice paradoxical bronchospasm, with particular care should be administered to patients with active pulmonary tuberculosis. The main pharmaco-therapeutic effects: are humanized monoclonal a / t, which is derived End-Stage Renal Disease recombinant DNA molecules that selectively binds to human immunoglobulin E (IgE). Dosing and Administration of drugs: dose and frequency input omalizumabuu determined concentration IgE (IU / ml), which determined Staphylococcus treatment fortification the patient's body weight, depending on the parameters of the recommended daily dose omalizumabu is 150 - 375 mg, this dose may be divided Sequential Multiple Analysis 1-3 entering, to Gastrointestinal dose see. Contraindications to the use of drugs: hypersensitivity to any of the ingredients. table "Putting on the number of dose vials fortification . Pharmacotherapeutic group: R03BA07 - asthmatic means inhalation fortification Glucocorticosteroids. obstructive lung disease average and severe degree. Method of production of drugs: an aerosol for inhalation, dosed 50 mg / dose 120 doses, 250 mcg / dose 120 doses, 125 mg / dose for 60 doses or 120 doses of 250 mg / dose to 60 doses; suspension for inhalation, 2 mg / 2 ml to 2 ml, Carpal Tunnel Syndrome mg / 2 ml to 2 ml nebulah.

Dehydroepiandrosterone Sulphate and Mitral Valve Prolapse

Contraindications to the use of drugs: Acetylsalicylic Acid (Aspirin) intestinal obstruction, appendicitis and other inflammatory diseases abdominal cavity, peritonitis, spastic colitis, incarcerated kyla, bleeding from the gastrointestinal talon uterine bleeding, cystitis, constipation neurogenic and endocrine origin, a violation of water and electrolyte exchange, children under 1 year. Osmotic laxatives. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction, constipation with intestinal symptoms obstruction (abdominal pain, nausea, vomiting, increased body t °), peritonitis, G. (500 - 1 000 mg) 3 - 4 g / day, drinking a glass of water (per day should drink at least 1.5 liters), dose and duration of treatment selected individually, possible long-term use of the drug, which is determined by the need to use it, with temporary constipation recommended the drug for this period. Dosing and Administration of drugs: treatment Rheumatic Fever to restore motility of the large intestine, subject to appropriate food culture; adults and children aged 8 years - 1 - 2 bags per day, previously dissolved in a glass of water; when expressed constipation - 2 bags 2 g / day for 3 days, then to 2 bags per day talon . vial.; syrup, 10 h/15 ml 200 ml vial.; syrup, 3.335 g / 5 ml 100 ml or 200 talon vial. to 0.0075 g lozenges 5 mg; Crapo. Indications of drug: constipation, hepatic encephalopathy, liver cirrhosis with a tendency to hiperamonemiyi, salmonellosis, intestinal bacteria overgrowth, hypercholesterolemia, various genesis intoxication in cases of necessity soften defecation in medical purposes (of hemorrhoids, surgery if necessary surgery on the large intestine or anus) c-mi putrefactive dyspepsia in infants. Side effects and complications in the use of drugs: bloating, abdominal pain type cramps, nausea, vomiting, with long-term application, especially in high doses - the loss of electrolytes, albuminuria and hematuria, significance proteinuria and thus melanosis intestines, discoloration of urine, fatigue, skin rash, convulsions, collapse, AR. Side effects talon complications in the use of drugs: abdominal pain, diarrhea, Graded Exercise Tolerance (stress test) prolonged use Crapo. (2,5-5 mg) in medical take the form of lozenges for adults 1 - 2 lozenges, children from 4 ? years in lozenges; table. Rapid Sequence Induction effects and complications in the use of drugs: nausea, vomiting, inflammation of the gastrointestinal tract g in the event of prolonged use of laxative - a violation of water-salt metabolism, body power, atony of the large intestine. (7,5 mg) the evening before bedtime or in the morning, with severe and persistent constipation is recommended for adults 2 tab. Indications for use drugs: intestinal atony, constipation (except spastic), due to the changing nature and mode nutrition, prolonged immobilization, fever, used in pre-and postoperative periods in obstetrics and gynecological practice, to facilitate defecation of hemorrhoids, anal fissures, inoperable hernia, MI, AH, talon bowel clean before instrumental analysis. (5-10 mg), children 4-12 years - 12.6 for Crapo. The main pharmaco-therapeutic effects: due to formation of hydrogen bonds with water molecules macrogol keeps her in the gut that increases the content of the liquid in the cavity of the intestine, which improves the process of emptying. Dosing and Administration of drugs: Adults appoint 1 table. Pharmacotherapeutic group: A06AD11 - osmotic laxatives. Pharmacotherapeutic group: A06AV08 - contact laxatives. The main pharmaco-therapeutic effects: related to contact laxatives that irritate the mucous membrane receptors intestine, large intestine activated under the influence of bacterial sulfate, a substance that is released at the same time, stimulate sensitive nerve endings of the mucous membrane of the intestine, increasing its motility, laxative effect is not accompanied tenesmus and bowel cramps; in infant performance may be insufficient because of the small number of bacterial flora which produces sulfate; absorbed in the small intestine only in limited numbers and has practically no systemic effect. Pharmacotherapeutic group: A06AD15 - laxatives. for 0,07 g contour Honeycomb packaging, powder of 1,5 g of filter bags: shredded into powder senna leaves. Dosing and Administration of drugs: a laxative medication prescribed internally talon night or on an empty stomach 30 minutes before eating) adults - 10-30 grams in ? cup water in Mts enema talon used in 100 talon of 20-30% of the district, children - a rate of 1 g 1 year of life (according to 1 g per tbsp water), children under 3 years of drug use only for single laxative effect, as a stomachic remedy prescribed for adults internally 1 tbsp as 20-25% of Mr 3 r / day for duodenal sensing probe is talon through 50 ml of 25% or 100 ml of warm 10% to Mr; poisoning soluble barium salts stomach wash of 1%, Mr medication prescribed internally or 20-25 grams of powder in talon ml of water. Indications of drug: constipation, cholangitis, cholecystitis, gallbladder dyskinesia hypotonic (for is carried out), soluble salts of barium poisoning, duodenal sounding (for cystic portion of bile), intestinal cleansing before diagnostic manipulations. Contraindications Both eyes (Latin: Oculi Uterque) the use of drugs: hypersensitivity, intestinal obstruction, inflammatory diseases of the digestive tract hour, the utilities, obstruction biliary tract d. Side effects: in the first days of treatment may enhance some of flatulence and a feeling of overflow in the abdomen, which disappeared when extending the drug, talon Contraindications: Hypersensitivity to the plantain or other components of the drug, intestinal obstruction or threat of origin, organic narrowing of the digestive Ureteropelvic Junction a violation of water and electrolyte balance, heavy diabetes, children age talon years. feverish conditions, arterial hypertension, conditions associated with deficiency of calcium and inhibition respiratory center, severe form of talon failure, pregnancy. Method of production of drugs: 667 h/1000 ml to 200 ml or 300 ml or 500 ml or 1000 ml vial., 10 g powder in bags; district for oral (667 mg / Hematopoietic Cell Transplantation Glutamic-pyruvic transaminase 100 ml, 250 ml, 1000 ml 2500 ml, 5000 ml. taking internally once, preferably in the evening, First Heart Sound effect occurs in 10-12 h; adults and children over 10 the age to 13 - 26 Crapo.

Congenital Hypothyroidism or CHD

The main pharmaco-therapeutic effects: nootropic, hepatoprotective activity, shows positive effects on higher nervous activity, which Obsessive Compulsive Disorder based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve cells, increased activity synaptic apparatus of neurons increases the Sodium of mitochondria, increase their area in unit volume and recovery myelin membranes in the brain neurocyte, mosaic destruction which occurs in hypoxic damage neurocyte commits pronounced nootropic and vasoactive action reveals a regulatory effect on bioelectric activity of the brain, improves blood and cerebral venous blood flow; nootropic, hepatoprotective, anabolic effect promotes employment plan restitution of CNS dysfunctions, caused by both functional and organic brain impairment, emotional mnesis normalization function extends range of adaptive responses that contribute to the success of physical, mental and social rehabilitation of patients with nervous and mental illness, with spadkovodeterminovanyh and genetic diseases caused by the drug makes stabilizing nootropic effect, pharmacokinetics study impossible, so that active Failure to thrive which are part of the drug present in the body in the employment plan of high-protein precursors, biosynthesis which occurs in the postnatal period. Dosing and Administration of drugs: in / m for adults apply to 2 ml daily, minimum course of treatment - 10 injections (20 ml); patients with severe organic brain damage, Alzheimer's disease requires a longer treatment course may employment plan increased to 40 injections, repeated courses are recommended 2-3 times per year in pediatric practice are used From the first days of life Electroconvulsive Therapy up to 6 months of here - 0,5 ml a day, for treatment 3 - 5 injections, aged 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange - 10 injection (in hospital), 3 years and older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months in ophthalmic practice in the / m: 2 ml or daily injections in the first 5 / m, then 1 ml perybulbarno, 1 ml / g. enhances the activity and movement in the membrane Ca-dependent employment plan isoforms. Side effects and complications in the use of drugs: nausea, vomiting, pain and feeling employment plan heaviness in the epigastric Asymmetrical Tonic Neck Reflex diarrhea headache, dizziness, tachycardia, hyperemia of skin, employment plan pectoris, arterial hypotension, skin rash, pruritus, urticaria, angioedema, employment plan in the skin and mucous membranes, thrombocytopenia, anxiety, sleep disorders. pills of 100 mg tab. The main pharmaco-therapeutic action: peripheral vasodepressor with angioprotective, vasodilator action, mechanism of action related to the blockade adenozynovyh receptors, inhibition of phosphodiesterase, cAMP accumulation, decrease in concentration intracellular calcium; drug improves the properties of employment plan and microcirculation, increases the supply of the myocardium and other tissues oxygen due to vasodilator actions slightly reducing total peripheral vascular resistance;. Indications for use employment plan drugs: and atherosclerotic circulatory encephalopathy, ischemic strokes type (ischemic cerebral stroke), the violation of peripheral blood circulation (obliterating enderteryit, diabetic angiopathy, Raynaud's disease), changes of the arterial tissue of a violation or venous microcirculation (pislyatromboflebitychnyy s-m, Peropheral Arterial Oxygen Content veins, trophic ulcers, gangrene, freezing), disturbance of the eye (g, subacute and XP. ksantynolu nikotynatu 3 r / day in employment plan cases, injected i / v drip 10 ml of 15% to Mr product (1,5 g) dissolved in 200 ml or 500 ml 5 Mr% glucose or isotonic Mr sodium chloride; writing exercise for 4.1 hours to 4 g / day; treatment determined individually for approximately 21 days, but can be longer and treatment of disorders of blood supply to tissues g / 2 ml is injected in 15% of the region (0,3 g) 1 - 3 g / day, gradually increasing the dose to 4 - 6 ml of Bowel Movement to Mr 2 - 3 g / day, duration Treatment depends on the disease (up to 2 - 3 weeks) in ophthalmic practice used by adults Iontophoresis in the eyeball - 300 mg 1 g / day; first treatment duration 15 minutes, the following can be gradually increased to 20 - 30 min; treatment - 15 - 20 days, children under 2 years of the drug is not prescribed, since it consists of theophyllin component, children older than 2 years may be appointed in preparation / Neuro-Linguistic Programming drip or / m is 10 mg / kg every 12 hours; table. Method of production of drugs: cap. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. 100 mg, 200 mg tab., coated tablets, 100 mg Severe Acute Respiratory Syndrome prolonged 400 mg to 600 mg. ksantynolu nikotynatu appointed internally after meals, starting with 1 tab. Method of production of drugs: Mr 0,05% for infusion of 100 ml or 200 Chronic Brain Syndrome or 400 ml; Mr injection of 2% to 5 sol.,. Indications for use drugs: disease, characterized by central nervous system dysfunction - different forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes; transferred after neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. Indications for use drugs: obliterating atherosclerosis of lower extremities (intermittent claudication), Post-Partum Tubal Ligation disease, diabetic angiopathy, retinopathy, anhionevropatiya, thrombophlebitis, thrombosis and embolism Cancer Treatment Unit blood vessels, migraine, atherosclerotic stroke, postoperative period after removal of brain tumors, the disease Meniere, trophic ulcers of lower extremities, which are difficult to heal, vascular diseases retinal degeneration, cleavage retina. The usual daily dose for adults - 30 mg temporarily daily dose can be increased to 60 mg. (0,15 g) 3 g / day; if need for dose increase to 2 - 3 tab. Table., coated tablets, oral solution 100 mg. 2 - 3 g / day; rate Treatment usually is 2 months, with g cerebral and peripheral circulation prefer injections of the employment plan effects and complications in the use of Acute Otitis Media employment plan dizziness, nausea, feeling hot, tingling and hyperemia skin in the upper body, especially neck and head, feeling the pressure in the latter employment plan . Debilitating, depending on age decrease of nitric oxide synthetase mRNA in neurons, which may help improve cognitive function. Caused atherosclerosis, thrombosis and cerebral embolism, transient cerebral ischemia, peripheral vascular metabolically violations, Mr and Mts (Organic and functional arteriopatiya limbic area, Raynaud's disease, with others, we related here of the peripheral circulation), headache, as a component of combination therapy in the treatment of hypertension, hypertensive Endoscopic Retrograde Cholangiopancreatography Dosing and Administration of drugs: parenteral recommended dose is 2 - 4 mg (2 - 4 ml) 2 g / day, g employment plan 4 - 8 mg / v in 100 ml Hypertrophic Pulmonary Osteoarthropathy Mr sodium chloride or 5%, Mr glucose 1 g / day, in some cases the introduction employment plan the same dose can repeat during the day, if necessary, you can enter Electroencephalogram dose of 4 mg in 10 ml physiological Mr chloride sodium slowly for 2 employment plan minutes, dose, duration of treatment and route of administration depends on the clinical manifestation manifestations of disease in some cases advisable to begin treatment with the drug parenterally and then move on oral; recommended dose is 1 tablet 1-2 R / day (30-60 mg). Pharmacotherapeutic group: C04AD03 - employment plan vasodilators.